Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 264,226 | 0.4% | 342,319 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 260,051 | 0.5% | 462,502 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 112,729 | 0.2% | 214,722 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 141,188 | 0.3% | 222,614 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 220,931 | 0.5% | 310,153 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 204,598 | 0.4% | 194,625 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 145,880 | 0.4% | 138,797 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 219,449 | 0.5% | 228,001 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 228,501 | 0.6% | 260,166 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 121,857 | 0.4% | 148,071 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 129,523 | 0.3% | 180,258 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 135,700 | 0.4% | 165,152 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 77,500 | 0.2% | 107,416 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 86,426 | 0.3% | 125,461 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 64,914 | 0.2% | 109,813 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 114,306 | 0.3% | 163,663 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 116,526 | 0.3% | 184,517 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 74,106 | 0.2% | 122,453 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 22,154 | 0.0% | 39,665 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 3,420 | 0.0% | 7,229 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,643 | 0.0% | 7,540 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 6,017 | 0.0% | 10,749 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 7,140 | 0.0% | 11,449 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 7,592 | 0.0% | 15,549 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 4,224 | 0.0% | 11,249 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 13,573 | 0.0% | 45,200 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 12,166 | 0.0% | 44,200 | 12/31/2013 |